Response to «Cutaneous eruptions associated with hematologic malignancies : the need for a unifying nomenclature»

Abstract

We read with interest Maglie et al's comments to "T‐cell papulosis associated with B‐cell malignancy (TCP‐BCM): a distinctive clinicopathologic entity"(1,2). These authors conducted a study focusing on "eosinophilic dermatosis of hematologic malignancies" (EDHM) and TCP‐BCM, and suggest that although this eruption is mostly associated with BCMs, it may also occur with other hematological malignancies (HM) such as acute myeloid leukemia or T‐cell lymphoma, or even different inflammatory conditions. In our study, we excluded non B‐cell malignancies because i) they are possibly associated with a wider spectrum of cutaneous manifestations (3,4) ii) in our clinical experience, TCP‐BCM was always associated with chronic lymphocytic leukemia (CLL).

This article is protected by copyright. All rights reserved.

http://bit.ly/2UvNskz